Aesthetics On Call（Honolulu, HI）

Aesthetics On Call operates as a hybrid medical wellness practice in Honolulu, Hawaii, led by Whitney Regan, PA-C, focusing on GLP-1 receptor agonist therapy for weight management alongside aesthetic medicine services. The clinic serves patients throughout Oahu who seek medically supervised weight loss programs that integrate pharmaceutical interventions with lifestyle modification support. Whitney Regan brings physician assistant training and aesthetic medicine experience to patient consultations, offering both in-person appointments at the Honolulu location and telehealth visits for established patients managing ongoing treatment protocols.

The practice prescribes semaglutide and tirzepatide, two GLP-1 receptor agonists that function by mimicking incretin hormones to regulate blood sugar and reduce appetite through delayed gastric emptying. Semaglutide therapy at Aesthetics On Call typically begins with 0.25 mg weekly subcutaneous injections, titrating upward based on patient tolerance and weight loss response over 16-20 week protocols. Tirzepatide programs utilize the dual GIP/GLP-1 receptor mechanism, starting at 2.5 mg weekly with gradual dose escalation to optimize metabolic effects while minimizing gastrointestinal side effects. Whitney Regan conducts initial assessments that include body composition analysis, metabolic health screening, and contraindication review before prescribing either peptide, with particular attention to patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Patients beginning GLP-1 therapy at Aesthetics On Call undergo comprehensive intake appointments where Whitney Regan reviews medical history, current medications, weight loss goals, and previous diet attempts to determine appropriate peptide selection and dosing strategy. The clinic provides injection technique training for home administration, supplies prescription medications through partnered compounding pharmacies, and schedules follow-up visits at four-week intervals during the initial titration phase. Monitoring protocols include tracking weight trends, assessing tolerance to dosage increases, adjusting nutritional intake to meet protein requirements despite reduced appetite, and identifying any adverse effects such as nausea, constipation, or injection site reactions that may require dose modification.

The Honolulu practice combines weight management services with aesthetic treatments, allowing patients to address body composition changes and skin quality concerns within a single clinical relationship. Whitney Regan’s approach emphasizes realistic goal-setting for GLP-1 therapy, typically projecting 10-15% body weight reduction over six months of treatment while counseling patients on the importance of resistance training to preserve lean muscle mass during caloric deficit periods. The clinic does not guarantee specific weight loss outcomes, as individual responses to semaglutide and tirzepatide vary based on baseline metabolic health, adherence to dosing schedules, dietary modifications, and genetic factors affecting incretin receptor sensitivity.

Aesthetics On Call structures its hybrid consultation model to accommodate Hawaii residents who prefer initial in-person evaluations followed by virtual check-ins for prescription refills and progress monitoring. The practice accepts patients from across Oahu, including Honolulu, Pearl City, Kailua, and surrounding communities, with telehealth options reducing travel requirements for ongoing weight management support. Whitney Regan maintains prescribing privileges in Hawaii and coordinates care with patients’ primary care physicians when GLP-1 therapy intersects with management of type 2 diabetes, hypertension, or other obesity-related conditions, ensuring treatment plans align with broader health objectives rather than functioning as isolated interventions.